Catalyst Event

Hanall Biopharma (009420) · Earnings Release

From Akros SCHK HK-Korea Cosmetics Index (ASHKCOS)

4/29/2026, 12:00:00 AM

Earnings ReleaseSentiment: Positive

Announcement of Q1 2026 financial results reporting an 11% YoY increase in revenue to KRW 40.0 billion and a swing to operating profit of KRW 800 million; a 5-10% price impact is estimated due to the turnaround. scheduled

Korean Translation

2026년 1분기 연결 매출 400억 원(전년 동기 대비 11% 증가) 및 영업이익 8억 원 흑자 전환 실적 발표 예정임. 실적 개선에 따른 5~10% 수준의 주가 상승이 예상됨. 예정됨

Related Recent Events

View Full Timeline